http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17992573

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase II|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 111
issn 1421-9786
1015-9770
issueIdentifier 1-2
pageRange 106-111
publicationName Cerebrovascular diseases (Basel, Switzerland)
startingPage 106
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_969ccf6fe026f2f48265f62ea5c814c6
bibliographicCitation Warach S, Kaufman D, Chiu D, Devlin T, Luby M, Rashid A, Clayton L, Kaste M, Lees KR, Sacco R, Fisher M; GAIN MRI Substudy. Effect of the Glycine Antagonist Gavestinel on cerebral infarcts in acute stroke patients, a randomized placebo-controlled trial: The GAIN MRI Substudy. Cerebrovasc Dis. 2006;21(1-2):106–11. PMID: 16340185; PMCID: PMC4753057.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0eb532c44cff0c799fcf6fdc528b04e2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3d8b5c4020b127958057c8e2777b457c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e1448909fe6b837fcf99408580d1ed38
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6281f2c4efdb2b3cf53bb0bc4dd44ec2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7ba439f4b268307cd8c95e9fdd7e0f1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_07d93fcee771b2ec26a66bfbc6c738c1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b5a9aefa8ff65e456814222ad8e6e6b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5522248e60b22b1a96608ed3f4cce3d0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_52e5bd1a52fb049d843948a8ef70d1f3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12eec7e11c7e11b5cf7a1c429016b80d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_78f399f6447dcf9fe3a115e17c9d5ffb
date 2006
identifier https://doi.org/10.1159/000090208
https://pubmed.ncbi.nlm.nih.gov/PMC4753057
https://pubmed.ncbi.nlm.nih.gov/16340185
isPartOf https://portal.issn.org/resource/ISSN/1015-9770
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20932
https://portal.issn.org/resource/ISSN/1421-9786
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Effect of the Glycine Antagonist Gavestinel on Cerebral Infarcts in Acute Stroke Patients, a Randomized Placebo-Controlled Trial: The GAIN MRI Substudy
discusses http://id.nlm.nih.gov/mesh/M0027996
http://id.nlm.nih.gov/mesh/M0011238
http://id.nlm.nih.gov/mesh/M0274791
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID750
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16759177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6450546
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8166
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7216
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67241466
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6746

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID116443
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID347827789
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID116444
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128090012
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2905
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2902
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2903
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2906
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127735632

Total number of triples: 54.